Newer fecal tests: Opportunities for professionals in laboratory medicine

Clinical Chemistry

Volumn 58, Issue 6, 2012, Pages 963-965

  Fraser, Callum G ^a   Allison, James E ^b,c   Young, Graeme P ^d   Halloran, Stephen P ^e  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d FLINDERS UNIVERSITY   (Australia)

^e UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; HEMOGLOBIN;

ANALYTIC METHOD; CANCER SCREENING; CLINICAL DECISION MAKING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; EDITORIAL; FECAL IMMUNOCHEMICAL TEST FOR HEMOGLOBIN; FECES ANALYSIS; FECES LEVEL; GASTROINTESTINAL DISEASE; GUAIAC BASED FECAL OCCULT BLOOD TEST; HEALTH CARE PERSONNEL; HUMAN; OCCULT BLOOD TEST; PATIENT IDENTIFICATION; PATIENT REFERRAL; POINT OF CARE TESTING; PRACTICE GUIDELINE; PROFESSIONALS IN LABORATORY MEDICINE;

FECES; FEMALE; HUMANS; INTESTINAL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; OCCULT BLOOD; POINT-OF-CARE SYSTEMS;

EID: 84861668241     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.185025     Document Type: Editorial

References (15)

1. Hoff G, Dominitz JA. Contrasting US and European approaches to colorectal cancer screening: Which is best? Gut 2010;59:407-14.
2. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
3. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
4. Kok L, Elias SG, Witteman BJM, Goedhard JG, Muris JWM, Moons KGM, de Wit NJ. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study. Clin Chem 2012;58:989-98.
5. Allison JE, Fraser CG, Halloran SP, Young GP. Comparing fecal immuno-chemical tests: improved standardization is needed. Gastroenterology 2012;142:422-4.
6. Fraser CG. Fecal occult blood tests. Life savers or outdated colorectal screening tools? Clin Lab News 2011;37:8 -10.
7. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al., and for the STARD Group. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 2003;49:1-6. (Pubitemid 36078546)
8. Ayling RM. New faecal tests in gastroenterology. Ann Clin Biochem 2012;49:44-54.
9. Jellema P, van der Windt DA, Bruinvels, DJ, Mallen CD, van Weyenberg SJ, Mulder CJ, de Vet HC. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ 2010;340:c1269.
10. Halloran SP, Launoy G, Zappa M. Faecal occult blood testing. In: Segnan N, Patnick J, von Karsa L, eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg: International Agency for Research on Cancer, Publications Office of the European Union; 2010. p 103-14.
11. McDonald PJ, Strachan JA, Digby J, Steele RJ, Fraser CG. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab Med [Epub ahead of print 2011 Dec 13].
12. Chen LS, Yen AM, Chiu SY, Liao CS, Chen HH. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011;12:551-8.
13. Omata F, Shintani A, Isozaki M, Masuda K, Fujita Y, Fukui T. Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol 2011;23:1036-41.
14. Marshall T, Lancashire R, Sharp D, Peters TP, Cheng KK, Hamilton W. The diagnostic performance of scoring systems to identify symptomatic colorectal cancer compared to current referral guidance. Gut 2011;60:1242-8.
15. Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, et al. An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem 2012; 58:483-5.